Related Experiment Video
Updated: Aug 2, 2026

Production of Apolipoprotein C-III Knockout Rabbits using Zinc Finger Nucleases
Published on: November 18, 2013
A case of apolipoprotein C-II deficiency with coronary artery disease
M Kawano1, K Kodama, H Inadera
1Integrated Medicine, Omiya Medical Center, Jichi Medical School, Saitama, Japan. mkkawano@jichi.ac.jp
Insights
This study details a rare case of heterozygous apolipoprotein C-II deficiency linked to coronary artery disease in a 56-year-old male. The findings suggest a potential role for lipoprotein abnormalities in the development of atherosclerosis.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Lipidology
Background:
- Apolipoprotein C-II (ApoC-II) deficiency is a rare genetic disorder characterized by severe hypertriglyceridemia and recurrent pancreatitis.
- Coronary artery disease (CAD) is a significant cause of morbidity and mortality, often associated with traditional risk factors.
Observation:
- A 56-year-old male with diagnosed apolipoprotein C-II deficiency presented with myocardial infarction and complete coronary artery occlusions.
- Lipid profile revealed significantly elevated postprandial triglycerides and low high-density lipoprotein cholesterol, with markedly reduced plasma apolipoprotein C-II levels.
- Genetic analysis did not identify mutations in the common exons of the apolipoprotein C-II gene.
Findings:
- The patient exhibited a very rare heterozygous form of apolipoprotein C-II deficiency.
- Coronary atherosclerosis was observed in the absence of pancreatitis, a common complication of ApoC-II deficiency.
- Lipoprotein abnormalities secondary to potential unidentified mutations in the apolipoprotein C-II gene are implicated in the development of CAD.
Implications:
- This case highlights the potential for apolipoprotein C-II deficiency, even in its heterozygous and potentially milder forms, to contribute to premature coronary artery disease.
- Further research into the genetic basis and clinical manifestations of less common apolipoprotein C-II deficiency variants is warranted.
- Understanding the link between specific lipoprotein abnormalities and atherosclerosis in rare genetic disorders can inform risk stratification and management strategies for cardiovascular disease.
Abstract:
A 56-year-old male with apolipoprotein C-II deficiency experienced a myocardial infarction without pancreatitis. A coronary angiogram showed complete occlusions of both the right and circumflex coronary arteries. His serum lipid levels were as follows: fasting total cholesterol 3.15 mmol/l; postprandial total cholesterol 3.62 mmol/l; fasting triglycerides 1.46 mmol/A; postprandial triglycerides 6.14 mmol/l; fasting high-density lipoprotein-cholesterol 0.47 mmol/l; and postprandial high-density lipoprotein cholesterol 0.36 mmol/l. His fasting level of plasma apolipoprotein C-II was 0.005 g/l, but his plasma levels of other apolipoproteins were within normal ranges. A DNA sequence analysis of the apolipoprotein C-II gene showed no mutations in exon 1, 2, 3, or 4, where most gene mutations related to apolipoprotein C-II deficiency occur. We report this patient's very rare heterozygous apolipoprotein C-II deficiency with coronary artery disease. Although this patient had some risk factors for coronary artery disease, coronary atherosclerosis in this patient might have occurred as a result of lipoprotein abnormalities caused by at least one mutation in the apolipoprotein C-II gene.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

